DOCSLIB.ORG

Presentation Virus Evasion of MHC Class I Molecule

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Presentation Virus Evasion of MHC Class I Molecule Virus Evasion of MHC Class I Molecule Presentation Jason L. Petersen, Chantey R. Morris and Joyce C. Solheim This information is current as J Immunol 2003; 171:4473-4478; ; of September 27, 2021. doi: 10.4049/jimmunol.171.9.4473 http://www.jimmunol.org/content/171/9/4473 Downloaded from References This article cites 96 articles, 45 of which you can access for free at: http://www.jimmunol.org/content/171/9/4473.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2003 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. THE JOURNAL OF IMMUNOLOGY BRIEF REVIEWS Virus Evasion of MHC Class I Molecule Presentation1 Jason L. Petersen,* Chantey R. Morris,* and Joyce C. Solheim2*†‡ he MHC class I H chain and the L chain that assembles docytosis of MHC class I molecules by the ARF6 pathway, and ␤ ␤ 3 with it, 2-microglobulin ( 2m), are cotranslationally the MHC molecules are recycled into the trans-Golgi network T inserted into the lumen of the endoplasmic reticulum via a process dependent on phosphoinositide 3-kinase (31, 32, ␤ (ER) (1). In the ER, the MHC/ 2m heterodimer binds peptide 43). However, the effect of Nef on HLA-A2 expressed in T lym- that is generated by proteasomal protein degradation in the cy- phocytes is predominantly inhibition of transport to the sur- tosol and translocated into the ER by the transporter associated face, rather than facilitation of endocytosis (10). The mecha- with Ag processing (TAP) (Fig. 1) (1, 2). Peptides can be fur- nism of MHC down-modulation may be MHC allele ther trimmed on their N termini by the ER aminopeptidase as- dependent and/or cell dependent (10). For example, the degree sociated with Ag presentation (3). The loading of peptides into of MHC class I cell surface reduction by Nef varies ϳ100-fold Downloaded from MHC class I molecules occurs in an assembly complex that in- depending on the type of cell examined (28, 30, 42, 44), sug- cludes TAP and other chaperones: tapasin, ERp57, and calre- gesting the involvement of cell-specific factors that either assist ticulin (2). Upon peptide binding, MHC class I molecules leave or interfere with Nef’s activity. the ER and traverse to the cell surface via Golgi and vesicular An interesting feature of Nef’s effect on MHC class I is its transport (1). At the surface, the peptides are exposed for rec- sequence specificity. For example, HIV-1 down-regulates http://www.jimmunol.org/ ognition by T lymphocytes able to lyse infected cells, an out- HLA-A and -B but has little impact on the expression of come that pressures viruses to take defensive measures (Table I; HLA-C and -E; this selectivity allows HIV-1-infected cells to Fig. 1) (4–39). Since the first descriptions of adenovirus protein escape lysis by NK cells (45). Physical interaction has been dem- ϳ binding to MHC class I molecules 20 years ago, there have onstrated between Nef and particular amino acid residues been many reports of virus counterattack strategies aimed at the present in the cytoplasmic tail of HLA-A2, but not in HLA-E cellular immune response. This mini-review will focus principally and in site-directed HLA-A2 mutants (27). Importantly, the on reports from the past year dealing with virus efforts against identification of specific binding sites for Nef on MHC mole- MHC class I peptide presentation, although background will be cules may lead to an understanding of differences in AIDS sus- provided to set the stage for each new development. ceptibility or resistance that are linked to particular MHC al- by guest on September 27, 2021 leles. In contrast to its effect on HLA-A2, Nef has very little HIV-1: Nef, Tat, and now Rev effect on murine MHC class I molecules (46), a finding that Considering the relatively small size of the HIV-1 genome, a further adds to our appreciation of the difficulty of deriving a sizable number of HIV-1 gene products have been implicated suitable small-animal model for AIDS. Studies with mouse/hu- in interference with MHC class I Ag presentation. The stron- man MHC chimeras indicate that amino acid residues in the gest evidence is for roles for Nef and Tat in this process. Nef is extracellular domains of the MHC molecule, as well as in the a protein that is unnecessary for HIV-1 replication, but that is cytoplasmic domain, can play a role in Nef-mediated MHC required for the development of the immune deficiencies asso- class I down-modulation (46). ciated with HIV infection (40). Nef increases the pathogenicity The HIV-1 tat gene encodes a protein that transactivates of HIV in several ways, including down-modulation of cell sur- HIV transcription (47). Tat is able to repress MHC class I pro- ␤ face MHC class I molecules (28, 30). Specific regions of Nef moter activity, as well as the activity of the promoter for 2m that are involved in MHC class I down-regulation have been (48–51). Tat is also capable of inhibiting the association of the identified (29, 41). CTL killing of HIV-1-infected primary 11S regulator subunit with the proteasome via a shared binding cells is inefficient if Nef is expressed, and the resistance of the site, interfering with the production of peptides for MHC bind- infected cells is due to MHC class I down-regulation (42). ing (17, 18). Tat is also secreted by HIV-infected cells (52). The To reduce MHC class I surface expression, Nef and phospho- presence of extracellular HIV-1 Tat indirectly affects MHC furin acidic cluster sorting protein-1 cooperate to cause the en- class I presentation by inhibiting dendritic cell phagocytosis of *Eppley Institute for Research in Cancer and Allied Diseases, and Departments of †Pathol- 2 Address correspondence and reprint requests to Dr. Joyce C. Solheim, Eppley Institute ogy and Microbiology and ‡Biochemistry and Molecular Biology, University of Nebraska for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Medical Center, Omaha, NE 68198 986805 Nebraska Medical Center, Omaha, NE 68198-6805. E-mail address: [email protected] Received for publication June 11, 2003. Accepted for publication August 4, 2003. 3 Abbreviations used in this paper: ␤ m, ␤ -microglobulin; ER, endoplasmic reticulum; The costs of publication of this article were defrayed in part by the payment of page charges. 2 2 TAP, transporter associated with Ag processing; MCMV, murine CMV; HCMV, human This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. CMV; US, unique short; UL, unique long; APLP2, amyloid precursor-like protein 2; Section 1734 solely to indicate this fact. Ad12, adenovirus type 12. 1 This work was supported by National Institutes of Health Grant GM57428 (to J.C.S.), by National Institutes of Health Training Grant T32 CA09476, and by National Institutes of Health Individual National Research Service Award Fellowships (to J.L.P. and C.R.M.). Copyright © 2003 by The American Association of Immunologists, Inc. 0022-1767/03/$02.00 4474 BRIEF REVIEWS: DOWN-REGULATION OF CLASS I MHC EXPRESSION BY VIRAL PROTEINS Downloaded from FIGURE 1. Diagram of MHC class I assembly and transport (1–3). MHC class I H chain and ␤ m assemble with peptide in a multimeric complex with 2 http://www.jimmunol.org/ calreticulin, ERp57, tapasin, and the TAP heterodimer in the ER (2). Certain viral proteins retard MHC class I egress or induce its turnover, in some cases by ejection of the molecules from the ER into the cytoplasm (4–16). Peptides are provided by proteasomal cleavage of ubiquitinated cytosolic proteins and TAP transport into the ER (2), and both TAP and the proteasome are known targets for viral interference (17–26). Within the ER, the peptides are N-terminally trimmed by ER aminopeptidase associated with Ag presentation (ERAAP) (3). Once peptide is bound, the complete MHC class I molecule is released from ER chaperones and proceeds through the Golgi (1). Via vesicular transport, the MHC class I molecule reaches the cell surface where it can present peptide to CTL (1). After the arrival of MHC class I molecules at the cell surface, certain virus proteins can cause their endocytosis. For example, HIV-1 Nef binds MHC class I on its cytoplasmic tail and escorts it from the cell membrane into the endosomal compartment (27, 28). These MHC molecules are subsequently degraded, or they are transported into the trans-Golgi with the assistance of protein transport proteins like phosphofurin acidic cluster sorting protein-1, adaptor protein complexes, and phosphoinositide 3-kinase (27, 29–32). Some virus proteins facilitate the endocytosis of MHC class I molecules by ubiquitination (33–37), and one of these proteins, the Kaposi’s sarcoma-associated herpesvirus K3 protein, has been specifically shown to direct these endocytosed MHC class I molecules to the lysosome by tumor susceptibility gene 101-dependent sorting (38, 39).
Load more

Recommended publications
  • Glossary - Cellbiology
    1 Glossary - Cellbiology Blotting: (Blot Analysis) Widely used biochemical technique for detecting the presence of specific macromolecules (proteins, mRNAs, or DNA sequences) in a mixture. A sample first is separated on an agarose or polyacrylamide gel usually under denaturing conditions; the separated components are transferred (blotting) to a nitrocellulose sheet, which is exposed to a radiolabeled molecule that specifically binds to the macromolecule of interest, and then subjected to autoradiography. Northern B.: mRNAs are detected with a complementary DNA; Southern B.: DNA restriction fragments are detected with complementary nucleotide sequences; Western B.: Proteins are detected by specific antibodies. Cell: The fundamental unit of living organisms. Cells are bounded by a lipid-containing plasma membrane, containing the central nucleus, and the cytoplasm. Cells are generally capable of independent reproduction. More complex cells like Eukaryotes have various compartments (organelles) where special tasks essential for the survival of the cell take place. Cytoplasm: Viscous contents of a cell that are contained within the plasma membrane but, in eukaryotic cells, outside the nucleus. The part of the cytoplasm not contained in any organelle is called the Cytosol. Cytoskeleton: (Gk. ) Three dimensional network of fibrous elements, allowing precisely regulated movements of cell parts, transport organelles, and help to maintain a cell’s shape. • Actin filament: (Microfilaments) Ubiquitous eukaryotic cytoskeletal proteins (one end is attached to the cell-cortex) of two “twisted“ actin monomers; are important in the structural support and movement of cells. Each actin filament (F-actin) consists of two strands of globular subunits (G-Actin) wrapped around each other to form a polarized unit (high ionic cytoplasm lead to the formation of AF, whereas low ion-concentration disassembles AF).
    [Show full text]
  • Exogenous Antigens Gain Access to the Major Histocompatibility Complex Class I Processing Pathway in B Cells by Receptor-Mediated Uptake Byyong Ke and Judith A
    Brief Definitive Report Exogenous Antigens Gain Access to the Major Histocompatibility Complex Class I Processing Pathway in B Cells by Receptor-mediated Uptake ByYong Ke and Judith A. Kapp From the Department of Pathology and Winship Cancer Center, Emory University School of Medicine, Atlanta, Georgia 30322 Summary Professional antigen-presenting cells, such as macrophages, dendritic cells, or B cells, take up soluble, exogenous antigens (Ags) and process them through the class II pathway, Several re- ports have shown that phagocytic macrophages also process particulate or soluble forms of ex- ogenous Ag via the class I pathway. By contrast, B cells normally do not process soluble, exog- enous Ag by way of the class I pathway unless Ags are directly introduced into the cytoplasm. Here we report that B cells present exogenous Ag via the class I pathway when Ags are taken up by receptor-mediated endocytosis. Thus, specialized methods of Ag uptake such as phago- cytosis or receptor-mediated endocytosis deliver exogenous Ag into the class I pathway of Ag processing and presentation. xogenous Ags are taken up nonspecifically by fluid- Materials and Methods phase pinocytosis or endocytosis, processed, and pre- E Antigens and Reagents. Chicken egg OVA, TNP, chloroquine, sented via class II pathway by professional APCs, such as brefeldin A, and phenazine methosulfate (PMS) were purchased macrophages, dendritic cells, or B cells. Exogenous Ags do from Sigma Chemical Co. (St. Louis, MO). Crystallized beef in- not enter the class I pathway of most cells (1-3). However, sulin was purchased from Lilly Research Labs (Indianapolis, IN). a small population of phagocytic macrophages can process TNP was conjugated to OVA or insulin as described (13).
    [Show full text]
  • It Takes Two to Tango
    HIGHLIGHTS IMMUNOTHERAPY It takes two to tango Much of the recent work on the development of active, specific immunotherapy of cancer has focused on the induction of CD8+ cytotoxic T-lymphocyte (CTL) responses, and several studies have shown that it is possible to stimulate tumour-specific CTLs using dendritic cells (DCs) that are loaded with tumour antigens. But CD4+ T-helper type 1 (TH1) cells are also important day of vaccination and loaded with various So, the results from this Phase I trial provide components of effective immune responses. MHC class-I- and -II-restricted peptides. convincing evidence that cryopreserved DCs In this study, Schuler–Thurner and Patients with incurable melanoma were can induce TH1 responses against tumour colleagues provide the first evidence that DCs treated with five biweekly vaccinations of antigens without significant toxicity, and it that are loaded with tumour-specific peptides DCs, followed by assessment one month also encourages further development of can rapidly induce TH1 responses in cancer after the final vaccination. DC-based vaccination technology. patients that are readily detectable ex vivo. The results showed that the vaccination Elaine Bell References and links The DCs that were used for vaccination protocol induced a rapid TH1 response in in this study were derived from blood patients, both to a control immunizing antigen ORIGINAL RESEARCH PAPER Schuler–Thurner, B. et al. Rapid induction of tumor-specific type 1 T helper cells in monocytes that were matured ex vivo using and also to defined MHC class-II-restricted metastatic melanoma patients by vaccination with mature, a defined cocktail (consisting of interleukin tumour antigens.
    [Show full text]
  • 1 ICAM3-Fc Outperforms Receptor-Specific Antibodies
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 10 April 2019 doi:10.20944/preprints201904.0118.v1 Peer-reviewed version available at Molecules 2019, 24, 1825; doi:10.3390/molecules24091825 ICAM3-Fc outperforms receptor-specific antibodies targeted nanoparticles to dendritic cells for cross-presentation Luis J. Cruz,1* Paul J. Tacken,2 Johan S. van der Schoot,2 Felix Rueda,3 Ruurd Torensma,2 Carl G. Figdor2* 1Translational Nanobiomaterials and Imaging, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. 2Department of Tumor Immunology, Radboud Insititute for Molecular Life Sciences, Radboud University Medical Center, Postbox 9101, 6500 HB Nijmegen, The Netherlands. 3Department of Biochemistry and Molecular Biology, University of Barcelona, Diagonal 643, 08028 Barcelona, Spain. Running title: ICAM3-Fc- versus antibody-targeted NP vaccines to human DCs Keywords: Delivery system; nanoparticle; targeting. AUTHOR INFORMATION Corresponding Author *Dr. Luis J. Cruz Translational Nanobiomaterials and Imaging, Department of Radiology, Bldg.1, C5-60. Leiden University Medical Center, Albinusdreef 2 2333 ZA Leiden, The Netherlands Tel: +31 71 5263025 Email: [email protected] *Prof. Dr. Carl G. Figdor Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Postbox 9101, 6500 HB Nijmegen, The Netherlands. Fax: +31-24-3540339; Tel.: +31-24-3617600; E-mail: [email protected] 1 © 2019 by the author(s). Distributed
    [Show full text]
  • Regulation of Calreticulin–Major Histocompatibility Complex (MHC) Class I Interactions by ATP
    Regulation of calreticulin–major histocompatibility complex (MHC) class I interactions by ATP Sanjeeva Joseph Wijeyesakerea, Jessica K. Gagnonb, Karunesh Arorab, Charles L. Brooks IIIb, and Malini Raghavana,1 aDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109; and bDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109 Edited by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved September 1, 2015 (received for review May 26, 2015) The MHC class I peptide loading complex (PLC) facilitates the assembly computational methods validated by experimental approaches, we of MHC class I molecules with peptides, but factors that regulate the identify residues within the globular domain of calreticulin that stability and dynamics of the assembly complex are largely unchar- are important for ATP binding and ATPase activity. Based on acterized. Based on initial findings that ATP, in addition to MHC class further investigations into the functional effects of calreticulin I-specific peptide, is able to induce MHC class I dissociation from the mutants with deficiencies in ATP interactions, we elucidate a key PLC, we investigated the interaction of ATP with the chaperone role for ATP in the regulation of PLC dynamics and the in- calreticulin, an endoplasmic reticulum (ER) luminal, calcium-bind- teraction of calreticulin with other cellular proteins. ing component of the PLC that is known to bind ATP. We combined computational and experimental measurements to identify residues Results within the globular domain of calreticulin, in proximity to the high- ATP Destabilizes the PLC, Promoting MHC Class I Release. Calreticulin- affinity calcium-binding site, that are important for high-affinity ATP deficient mouse embryonic fibroblasts (MEFs) reconstituted binding and for ATPase activity.
    [Show full text]
  • Elucidating the Signalling Pathway of Mer Tyrosine Kinase Receptor in Efferocytosis
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 8-19-2014 12:00 AM Elucidating the Signalling Pathway of Mer Tyrosine Kinase Receptor in Efferocytosis Ekenedelichukwu Azu The University of Western Ontario Supervisor Dr. Bryan Heit The University of Western Ontario Graduate Program in Microbiology and Immunology A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Science © Ekenedelichukwu Azu 2014 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Cell Biology Commons, Immunity Commons, Molecular Biology Commons, and the Other Immunology and Infectious Disease Commons Recommended Citation Azu, Ekenedelichukwu, "Elucidating the Signalling Pathway of Mer Tyrosine Kinase Receptor in Efferocytosis" (2014). Electronic Thesis and Dissertation Repository. 2260. https://ir.lib.uwo.ca/etd/2260 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. ELUCIDATING THE SIGNALLING PATHWAY OF MER TYROSINE KINASE RECEPTOR IN EFFEROCYTOSIS Thesis format: Monograph by Ekenedelichukwu Azu Graduate Program in Microbiology and Immunology A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science The School of Graduate and Postdoctoral Studies The University of Western Ontario London, Ontario, Canada © Ekenedelichukwu Azu 2014 Abstract Efferocytosis is the clearance of apoptotic cells and is necessary for homeostasis. Mer Tyrosine Kinase (MerTK) is a crucial efferocytic receptor whose loss is associated with chronic inflammatory diseases and autoimmunity. While previous studies have shown that MerTK mediates efferocytosis through a unique mechanism that requires integrins, MerTK signalling pathway remains unknown.
    [Show full text]
  • Efficient Elimination of Primary B-ALL Cells in Vitro and in Vivo Using A
    Open access Original research J Immunother Cancer: first published as 10.1136/jitc-2020-000896 on 11 August 2020. Downloaded from Efficient elimination of primary B- ALL cells in vitro and in vivo using a novel 4- 1BB- based CAR targeting a membrane- distal CD22 epitope 1 1 1 Talia Velasco- Hernandez , Samanta Romina Zanetti , Heleia Roca- Ho, Francisco Gutierrez- Aguera,1 Paolo Petazzi,1 Diego Sánchez- Martínez,1 Oscar Molina,1 Matteo Libero Baroni,1 Jose Luis Fuster,2 Paola Ballerini,3 1,4 5 6,7 Clara Bueno, Narcis Fernandez- Fuentes, Pablo Engel , Pablo Menendez1,4,7,8 To cite: Velasco- Hernandez T, ABSTRACT BACKGROUND Zanetti SR, Roca- Ho H, et al. Background There are few therapeutic options available for B-cell acute lymphoblastic leukemia (B-ALL) Efficient elimination of primary patients with B- cell acute lymphoblastic leukemia (B- ALL) is an aggressive cancer, diagnosed at any age B- ALL cells in vitro and in vivo – using a novel 4- 1BB- based relapsing as CD19 either after chemotherapy or CD19- throughout the lifespan of an individual, CAR targeting a membrane- targeted immunotherapies. CD22- chimeric antigen receptor being the most common malignancy in distal CD22 epitope. Journal (CAR) T cells represent an attractive addition to CD19- CAR children.1 Despite current 5-year disease- + – for ImmunoTherapy of Cancer T cell therapy because they will target both CD22 CD19 free survival rates of ~80%, refractory and 2020;8:e000896. doi:10.1136/ B- ALL relapses and CD19– preleukemic cells. However, jitc-2020-000896 relapsed (R/R) patients have a dismal prog- the immune escape mechanisms from CD22- CAR T cells, nosis.2–7 Adult B- ALL is less frequent, but is and the potential contribution of the epitope binding of the commonly associated with an unfavorable ► Additional material is anti-CD22 single-chain variable fragment (scFv) remain published online only.
    [Show full text]
  • Cell Biology from an Immune Perspective in This Lecture We Will
    Harvard-MIT Division of Health Sciences and Technology HST.176: Cellular and Molecular Immunology Course Director: Dr. Shiv Pillai Cell Biology from an Immune Perspective In this lecture we will very briefly review some aspects of cell biology which are required as background knowledge in order to understand how the immune system works. These will include: 1. A brief overview of protein trafficking 2. Signal transduction 3. The cell cycle Some of these issues will be treated in greater depth in later lectures. Protein Trafficking/The Secretory Pathway: From an immune perspective the secretory compartment and structures enclosed by vesicles are “seen” in different ways from proteins that reside in the cytosol or the nucleus. We will briefly review the secretory and endocytic pathways and discuss the biogenesis of membrane proteins. Some of the issues that will be discussed are summarized in Figures 1-3. Early endosomes Late endosomes Lysosomes Golgi Vesiculo-Tubular Compartment ER Figure 1. An overview of the secretory pathway Early endosomes Late endosomes Multivesicular and multilamellar bodies Golgi ER Proteasomes Figure 2. Protein degradation occurs mainly in lysosomes and proteasomes Proteins that enter the cell from the environment are primarily degraded in lysosomes. Most cytosolic and nuclear proteins are degraded in organelles called proteasomes. Intriguingly these two sites of degradation are each functionally linked to distinct antigen presentation pathways, different kinds of MHC molecules and the activation of different categories of T cells. Integral membrane proteins maybe inserted into the membrane in a number of ways, the two most common of these ways being considered in Figure 3.
    [Show full text]
  • Innate Immunity: MHC Class I As a Negative Regulator of TLR Signalling
    RESEARCH HIGHLIGHTS IN BRIEF T RANSPLANTATION Handling complement for transplant success Haematopoietic cell transplantation (HCT) is used to treat cancer and blood disorders, but a potentially lethal complication is the development of graft-versus-host disease (GVHD). Total-body irradiation (TBI) is required to facilitate HCT and can promote GVHD by activating host dendritic cells (DCs), although the mechanisms involved are not completely understood. This study shows that, in mice, TBI causes host DCs to upregulate the complement components C3, C5a, factor B and factor D, and to downregulate CD55, a negative regulator of the complement cascade. In HCT using CD55-deficient donor T cells, recipient mice developed exacerbated GVHD, suggesting that upregulation of complement components by host DCs promotes the activation of allogeneic donor T cells. Indeed, less severe GVHD was seen in HCT using donor T cells that were deficient in the C3a and C5a receptors. Treatment of recipients with a C5a receptor antagonist during the post-transplantation period reduced GVHD development, and could be a useful strategy for preventing GVHD in humans after transplantation. ORIGINAL RESEARCH PAPER Kwan, W.-H. et al. Antigen-presenting cell-derived complement modulates graft-versus-host disease. J. Clin. Invest. 15 May 2012 (doi:10.1172/JCI61019) T CELLS ‘Leaky’ cytokine secretion by immunological synapses This study used live-cell imaging to investigate whether cytokine secretion by activated T cells is restricted by the immunological synapse to antigen-specific target cells or also affects bystander cells in the local environment. Responses to interferon-γ (IFNγ) were monitored by tracking the intracellular localization of a fluorescent STAT1 protein in ovalbumin- expressing and non-expressing astrocytes cultured with activated ovalbumin-specific CD8+ T cells.
    [Show full text]
  • Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
    University of Massachusetts Medical School eScholarship@UMMS Open Access Publications by UMMS Authors 2021-03-09 Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation Karthik Dhatchinamoorthy University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Amino Acids, Peptides, and Proteins Commons, Biological Factors Commons, Cancer Biology Commons, Hemic and Immune Systems Commons, Immunopathology Commons, Neoplasms Commons, and the Pathology Commons Repository Citation Dhatchinamoorthy K, Colbert JD, Rock KL. (2021). Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Open Access Publications by UMMS Authors. https://doi.org/10.3389/ fimmu.2021.636568. Retrieved from https://escholarship.umassmed.edu/oapubs/4636 Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Publications by UMMS Authors by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. REVIEW published: 09 March 2021 doi: 10.3389/fimmu.2021.636568 Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation Karthik Dhatchinamoorthy, Jeff D. Colbert and Kenneth L. Rock* Department of Pathology, UMass Medical School, Worcester, MA, United States Major histocompatibility class I (MHC I) molecules bind peptides derived from a cell’s expressed genes and then transport and display this antigenic information on the cell surface. This allows CD8T cells to identify pathological cells that are synthesizing abnormal proteins, such as cancers that are expressing mutated proteins.
    [Show full text]
  • The MHC Class I–Like Fc Receptor Promotes Humorally Mediated Autoimmune Disease Shreeram Akilesh, Stefka Petkova, Thomas J
    Research article The MHC class I–like Fc receptor promotes humorally mediated autoimmune disease Shreeram Akilesh, Stefka Petkova, Thomas J. Sproule, Daniel J. Shaffer, Gregory J. Christianson, and Derry Roopenian The Jackson Laboratory, Bar Harbor, Maine, USA. The MHC class I family–like Fc receptor, FcRn, is normally responsible for extending the life span of serum IgG Ab’s, but whether this molecule contributes to autoimmune pathogenesis remains speculative. To deter- mine directly whether this function contributes to humoral autoimmune disease, we examined whether a defi- ciency in the FcRn heavy chain influences autoimmune arthritis in the K/BxN mouse model. FcRn deficiency conferred either partial or complete protection in the arthritogenic serum transfer and the more aggressive genetically determined K/BxN autoimmune arthritis models. The protective effects of an FcRn deficiency could be overridden with excessive amounts of pathogenic IgG Ab’s. The therapeutic saturation of FcRn by high-dose intravenous IgG (IVIg) also ameliorated arthritis, directly implicating FcRn blockade as a signifi- cant mechanism of IVIg’s anti-inflammatory action. The results suggest that FcRn is a potential therapeutic target that links the initiation and effector phases of humoral autoimmune disease. Introduction mice been used as a model for addressing this question with mixed At the inductive phase of a humoral autoimmune response, B results (refs. 9–16; D. Roopenian, unpublished observations). This cells, after encounter with APCs and T cells, undergo antigen- is not surprising because β2m controls many immunological and driven proliferation and differentiation into Ab-secreting plasma nonimmunological processes, including the development and cells. During the effector phase, Ab’s bind autoantigen leading function of CD8 T cells, natural T cells, conventional NK cells (17), to downstream events such as activation of complement, recruit- and iron homeostasis (18).
    [Show full text]
  • Mechanisms of HIV Protein Degradation Into Epitopes: Implications for Vaccine Design
    Viruses 2014, 6, 3271-3292; doi:10.3390/v6083271 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Mechanisms of HIV Protein Degradation into Epitopes: Implications for Vaccine Design Marijana Rucevic †, Julie Boucau †, Jens Dinter †, Georgio Kourjian † and Sylvie Le Gall * Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital and Harvard Medical School, Cambridge, MA 02139, USA; E-Mails: [email protected] (M.R.); [email protected] (J.B.); [email protected] (J.D.); [email protected] (G.K.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-857-268-7010. Received: 11 June 2014; in revised form: 6 August 2014 / Accepted: 11 August 2014 / Published: 21 August 2014 Abstract: The degradation of HIV-derived proteins into epitopes displayed by MHC-I or MHC-II are the first events leading to the priming of HIV-specific immune responses and to the recognition of infected cells. Despite a wealth of information about peptidases involved in protein degradation, our knowledge of epitope presentation during HIV infection remains limited. Here we review current data on HIV protein degradation linking epitope production and immunodominance, viral evolution and impaired epitope presentation. We propose that an in-depth understanding of HIV antigen processing and presentation in relevant primary cells could be exploited to identify signatures leading to efficient or inefficient epitope presentation in HIV proteomes, and to improve the design of immunogens eliciting immune responses efficiently recognizing all infected cells. Keywords: HIV; antigen processing; protein degradation; proteasome; aminopeptidase; peptidase; immunogen; vaccine vector; dendritic cells; T cells; viral evolution Viruses 2014, 6 3272 1.
    [Show full text]